PITTSBURGH, April 8, 2026 /PRNewswire/ — “Our intention is to create a more accurate and exact wearable device to determine the onset of the female ovulation cycle and consequently when a female human or animal is most likely to become pregnant after insemination,” stated one of the two inventors, from Gainesville, Virginia, “hence the invention of the Ovulonics device. Our design would provide an easy, convenient and accurate detection time for human or animal

Biomedical researchers have designed an injectable microgel to help reduce bleeding in infants who require surgical care. In an animal model, the engineered microgel reduced bleeding by at least 50%. The paper, “Hemostatic B-Knob Triggered MicroGels (BK-TriGs) to Address Bleeding in Neonates,” is published in the journal Science Advances.

Ovarian cancer remains the deadliest gynecologic cancer, largely because it is rarely found early. Symptoms are often vague, and existing screening approaches—such as blood tests and transvaginal ultrasound—can miss the disease at stages when treatment is most effective. In recent years, research has reshaped understanding of how many aggressive ovarian cancers begin, pointing not to the ovary itself, but to the fallopian tubes. That shift has created a need for tools that can safely examine these narrow structures for early changes linked to cancer.